Optovue Releases AngioVueHD Imaging High-Density OCT Angiography

Source: Optovue

Optovue commercially released its AngioVueHD Imaging, higher density OCTA imaging that provides improvement in resolution and peripheral visualization of vasculature in the eye, according to a company news release. AngioVueHD Imaging provides OCTA scans with 73 percent more sampling points and improves image resolution by approximately 33 percent over the existing field-of-view, enabling physicians to more closely assess the fine vasculature in the eye for changes that could indicate ocular disease

“The improved density of AngioVueHD provides the high resolution resembling that of 3x3 millimeter scans – the size we previously used to obtain the highest image quality – yet in a larger, 6x6 millimeter format," Nadia Waheed, MD, MPH, associate professor of Ophthalmology at Tufts Medical School and director of the Boston Image Reading Center, said in a news release. "As a result, we have much greater image resolution for the 6x6 millimeter field-of-view, allowing for better assessment of pathologies characterized by large or oblique lesions.”

One of the major challenges of OCTA imaging is the limited region of the eye that can be visualized for assessing fine microvasculature. Currently, the standard field-of-view for the best image quality measures 3x3 millimeters. Optovue says it has significantly improved image quality in the 6x6 millimeter field-of-view with the AngioVueHD update to its AngioVue Imaging option. The feedback from early clinical evaluators of the AngioVueHD enhancements suggests the new 6x6 millimeter OCTA scan enables the improved likelihood of detecting abnormalities and assessing fine microvasculature details that would typically extend beyond the central 3x3 millimeter region.

The company also released AngioVueHD Montage, which automatically combines two high-density images – one at the central macular region, and the other centered at the optic disc – in a 10x6 millimeter field-of-view. The ability to automatically create the montage is useful for imaging vasculature in potential pathologies that may extend into the periphery of the imaging plane. 

“Extending the AngioVueHD to include an automatic montage in an even wider 10x6 millimeter format will assist me in understanding lesions as they arise outside the macula,” Dr. Waheed said.

“AngioVueHD will become the new gold standard in OCTA imaging and it will transform the way physicians use this technology to care for their patients,” Jay Wei, founder and chief executive officer at Optovue, said in the news release. “Our AngioVue platform is already providing eye care professionals with a faster, noninvasive imaging technique that provides superior image quality of retinal and choroidal microvasculature. With the new, higher density image resolution in a larger field-of- view, we have raised the bar for OCTA imaging.”

AngioVueHD will be highlighted at the upcoming annual meetings: Vision Source in Nashville, May 4-6, booth #202; ASCRS in Los Angeles, May 6-8, booth #1215; ARVO in Baltimore, May 7-10, booth #3612.


Related Content